HPV Vaccine Still Highly Effective 17 Years After Introduction | Managed Healthcare Executive

HPV Vaccine Effectiveness

A recent study in JAMA Pediatrics found the HPV vaccine to be highly effective 17 years after its introduction, reducing cancer risk in young women.

Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide, with low-risk types causing genital warts and high-risk types linked to cancers of the cervix, anus, and oropharynx.

The vaccine continues to provide strong protection for young women, even for those who did not complete the full series of doses.

The study highlights the enduring effectiveness of the HPV vaccine in reducing cancer risk among young women.

Author summary: HPV vaccine remains highly effective 17 years after introduction.

more

Managed Healthcare Executive Managed Healthcare Executive — 2025-10-31

More News